Drinking and Memory Loss

Drinking is a very common habit amongst the middle aged men across the globe. It has led to many adverse changes to the health of the consumers. Drinking may be the reason for an accelerated memory loss and mental decay, according to a new study. Premature Old age may also be caused due to heavy drinking earlier.

Heavy drinking in mid-life is associated with faster cognitive declines for men, a new study suggests. However, lighter drinking didn't appear to accelerate mental decline. Men who consume more than two alcoholic drinks per day during their middle age may speed up the process of memory loss and premature old age up to six years. For women, no clear result was derived.

The research was carried out by a group of scientists. It was carried out on 5000 civil servants. The decline was equal to two extra years of aging for a combined measure of mental capabilities like reasoning, and six years of memory relevant product/services. The heavy drinkers were compared to those men who drank moderately or refrained from it.

Research has deduced that middle-aged men are at a greater risk of mental decay, because they are into heavy drinking for many years.  They have been drinking all their lives, which makes their brain vulnerable to memory loss.

Bentham Science Publishers is one of the leading STM publishing companies of the industry. It publishes more than 116 online and print journals and more than 300 eBooks. One of its journals is “Current drug Abuse Reviews.” Current Drug Abuse Reviews aim to publish the highest quality reviews, meta-analyses and drug clinical trial studies on all latest advances on alcohol and drug abuse and addiction.

Diabetes and Google

Diabetes is one of the most life-threatening diseases in the whole world. According to WHO, 347 million people, worldwide, have diabetes. The leading organization also predicts that by 2030, diabetes will be the 7^th leading cause of deaths. The two types of diabetes vary in some characteristics, but the damage to the body is similar. The term “diabetes mellitus” describes a metabolic disorder of multiple etiology characterized by chronic hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action, or both”.

Diabetes can harm the patients internally and externally. High sugar levels can lead to kidney failure, eyesight weakening, heart diseases and many more. For diabetic patients tired with having to use pin prick blood tests every now and then to monitor their blood sugar levels, the good news is that Google has invented a novel pair of contact lenses to keep their glucose levels in check. The contact lenses have special sensors, minute transistors and a microscopic hair-thin antenna. The readings are then wirelessly transmitted to a handheld monitor device

Many patients have to administer pin pricks, sometimes more than 10 times in a single day in order to keep an eye on their glucose levels, as is evident from the case of Michael Vahradian, who finds it rather cumbersome to use them. Google lens, which will be available in markets in about 5 years, will revolutionize the way diabetes blood sugar levels are monitored and will ease the process for millions around the world.

Google is best known as a search engine and advertising company. However, it has launched a number of other useful wearable products, like Google Glass and a special pair of glasses fitted with cameras and a small computer display. Although, research on contact lenses for monitoring blood sugar levels started many years ago at the University of Washington, it was Google really which made the project a reality. The man behind the invention, Brian Otis expresses his opinion:

“You can take it to a certain level in an academic setting, but at Google we were given the latitude to invest in this project.”

Readers can refer to Current Diabetes Reviews by Bentham Science Publishers for the latest developments in the field of diabetes and its cures. A Bentham eBook, Epidemiology of Type 2 Diabetes is also a useful guide on diabetes epidemiology.

Diabetes Can Lead To Cancer!

Diabetes is one of the most life-threatening diseases in the whole world. According to WHO, 347 million people worldwide have diabetes. The leading organization also predicts that by 2030, diabetes will be the 7^th leading cause of deaths.

The two types of diabetes vary in some characteristics but the damage to the body is similar. The term “diabetes mellitus” describes a metabolic disorder of multiple aetiology characterized by chronic hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action, or both”.

Bentham Science Publishers is one of the leading journals in the STM industry. It has journals and eBooks pertaining to topics from science, medicine, technology and the like. One of the journals is Endocrine, Metabolic & Immune Disorders - Drug Targets. This journal is devoted to timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Original articles related to Immune Disorders and Drug Targeting are also considered for publication.

A new research has proven that a drug used to treat the patients of the Type 2 diabetes, may lead to increased risk of bladder cancer. Type 2 diabetes (formerly called non-insulin-dependent or adult-onset) results from the body’s ineffective use of insulin. Type 2 diabetes comprises 90% of people with diabetes around the world, and is largely the result of excess body weight and physical inactivity.

This recent research may increase the rate of death among diabetic patients due to drug induced bladder cancer. The researchers have conducted a systematic review and meta-analysis to determine the chances of bladder cancer in adults suffering from type 2 diabetes mellitus using thiazolidinediones. They suggested that type 2 diabetic patients have 40% more chances of development of cancer.

This study is very helpful for physicians who are specialist in diabetes management and treatment. It would be very healthy for patients if they are not prescribed pioglitazone rather there are various other Antidiabetic drugs that could be prescribed and they do not have any carcinogenic effect.